Position in NTRA
as of Mar 31, 2026
· filed Apr 23, 2026
Position Value
$8,859,557
-$1,346,402 QoQ
Shares Held
44,300
-0.6% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
7.91%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 92.83295711060948.ToString("F0")%
Shared 0.ToString("F0")%
None 7.16704288939052.ToString("F0")%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026PERKINS CAPITAL MANAGEMENT INC holds $23,879,825 across 9 Diagnostics & Research names. NTRA ranks #1 (37.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
This page
|
44,300 | $8,859,557 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
9,700 | $5,450,333 | |
| 3 | MDXH |
MDxHealth SA
|
1,476,441 | $3,395,814 | |
| 4 | VCYT |
Veracyte, Inc.
|
75,333 | $2,426,475 | |
| 5 | PSNL |
Personalis, Inc.
|
239,000 | $1,522,430 | |
| 6 | NEO |
Neogenomics Inc
|
132,350 | $982,037 | |
| 7 | BDSX |
Biodesix Inc
|
44,783 | $649,353 | |
| 8 | CSTL |
Castle Biosciences Inc
|
15,415 | $378,438 |
All Filings in NTRA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,859,557 | 44,300 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $10,205,959 | 44,550 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $7,219,504 | 44,850 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $7,729,005 | 45,750 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $7,045,753 | 49,825 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $8,021,852 | 50,675 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $6,899,732 | 54,350 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $6,232,089 | 57,550 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $5,499,032 | 60,125 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,875,850 | 61,875 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $2,740,181 | 61,925 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $3,026,652 | 62,200 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $3,481,104 | 62,700 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $2,486,523 | 61,900 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $2,719,031 | 62,050 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $2,292,968 | 64,700 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $2,375,712 | 58,400 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $5,622,078 | 60,200 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $6,953,856 | 62,400 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $7,089,948 | 62,450 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $6,493,483 | 63,950 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $6,573,296 | 66,050 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $5,107,368 | 70,700 | Shares | Sole | 2020-10-28 | |
| 2020-03-31 | $2,205,161 | 73,850 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||